In 2023, the mortality rate for liver malignant neoplasms in Canada stood at X units per hundred thousand persons. By 2024, it is forecasted to be 9.6, gradually increasing to 10.3 by 2028. The forecast from 2024 to 2028 indicates a steady upward trajectory. The year-on-year increase from 2024 to 2025 is approximately 2.08%, followed by rises of 1.02%, 2.02%, and 1.98% in subsequent years. The compound annual growth rate (CAGR) over this five-year period is projected at approximately 1.76%.
Future trends to watch for include advancements in medical treatments and early detection technologies that may influence mortality rates. Additionally, public health campaigns focusing on liver health and lifestyle changes could also impact these forecasts. Monitoring changes in these areas will be crucial for understanding the future trajectory of liver cancer mortality in Canada.
